VKTX - Viking Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts0067
Avg. Estimate00-0.44-0.5
Low Estimate00-0.52-0.6
High Estimate00-0.4-0.42
Year Ago EPS-0.14-0.08-0.79-0.44
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts7377
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History12/30/20173/30/20186/29/20189/29/2018
EPS Est.-0.18-0.13-0.11-0.12
EPS Actual-0.14-0.08-0.13-0.11
Difference0.040.05-0.020.01
Surprise %22.20%38.50%-18.20%8.30%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate00-0.44-0.5
7 Days Ago-0.1-0.1-0.44-0.5
30 Days Ago-0.12-0.1-0.45-0.48
60 Days Ago-0.12-0.1-0.46-0.49
90 Days Ago-0.12-0.09-0.46-0.49
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/A11
Up Last 30 Days6N/A64
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesVKTXIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.48
Next Qtr.N/AN/AN/A0.32
Current Year44.30%N/AN/A0.20
Next Year-13.60%N/AN/A0.09
Next 5 Years (per annum)40.00%N/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A